AACS and systemic lupus erythematosus: NZB/W mice in this accelerated lupus model were treated with aCSF1, aIL34, or aCSF1/IL34, or with Cytoxan or aRW as controls to examine whether inhibiting macrophage/monocyte differentiation impacts proteinuria or survival (Supplementary Figure 9A).